Skip to content
ClinCalc Pro
Menu
Cholinergic — Intraocular Miotic (Cataract Surgery)

Acetylcholine 1% Intraocular Solution

Brand names: Miochol-E

Intraocular acetylcholine solution is a cholinergic agent instilled into the anterior chamber during ophthalmic surgery to produce rapid, short-lived miosis after lens delivery or other anterior segment procedures.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

As a direct muscarinic agonist it stimulates the iris sphincter muscle to contract, constricting the pupil promptly when applied directly within the eye.

Prescribing in practice

  • It is for intraocular surgical use only and must be prepared and used immediately, as the solution is unstable in solution once reconstituted.
  • Systemic muscarinic effects such as bradycardia, hypotension, bronchospasm and increased secretions can occur and should be anticipated peri-operatively.
  • Caution applies in patients with asthma, significant bradyarrhythmia, peptic ulcer disease or other conditions sensitive to cholinergic stimulation.

Monitoring

Monitor heart rate, blood pressure and respiratory status during and immediately after intraocular use given the potential for systemic cholinergic effects.

Counselling the patient

  • This medicine is used by the surgeon inside the eye during your operation to make the pupil smaller.
  • It acts only briefly during surgery.
  • Any feeling of flushing, a slow pulse or wheeze during the procedure will be managed by the theatre team.

Evidence & guidelines

Intraocular acetylcholine is a well-established agent for producing rapid miosis during anterior segment surgery, used per its SPC.

Reference: ESCRS Cataract Surgery Guidelines; SPC Miochol-E; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.